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Background: Reactive oxygen species (ROS) are essential for normal physiological functioning of the brain. However,
uncompensated increase in ROS levels may results in oxidative stress. Phospholipase A2 (PLA2) is one of the key players
activated by elevated ROS levels resulting in the hydrolysis of various products from the plasmamembrane such as
peroxidized fatty acids. Free fatty acids (FFAs) and fatty acid metabolites are often implicated to the genesis of cognitive
impairment. Previously we have shown that age-, and experimentally induced oxidative stress causes PLA2-dependent
long-term memory (LTM) failure in an aversive operant conditioning model in Lymnaea stagnalis. In the present study,
we investigate the effects of experimentally induced oxidative stress and the role of elevated levels of circulating FFAs
on LTM function using a non-aversive appetitive classical conditioning paradigm.
Results: We show that intracoelomic injection of exogenous PLA2 or pro-oxidant induced PLA2 activation negatively
affects LTM performance in our learning paradigm. In addition, we show that experimental induction of oxidative
stress causes significant temporal changes in circulating FFA levels. Importantly, the time of training coincides with
the peak of this change in lipid metabolism. However, intracoelomic injection with exogenous arachidonic acid, one
of the main FFAs released by PLA2, does not affect LTM function. Moreover, sequestrating circulating FFAs with the
aid of bovine serum albumin does not rescue pro-oxidant induced appetitive LTM failure.
Conclusions: Our data substantiates previous evidence linking lipid peroxidation and PLA2 activation to age- and
oxidative stress-related cognitive impairment, neuronal dysfunction and disease. In addition however, our data indicate
that lipid peroxidation induced increased levels of circulating (per)oxidized FFAs are not a factor in oxidative stress
induced LTM impairment.
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Reactive oxygen species (ROS) play an important and
critical role in synaptic plasticity and memory formation
[1,2]. However, high levels of ROS are also shown to
cause detrimental effects in the brain that negatively
affect neuronal plasticity and memory function [3,4]. For* Correspondence: wilderin@ucalgary.ca
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unless otherwise stated.instance, excessive (experimentally) increased levels of
ROS are associated with decreased cognitive performance
in both vertebrate and invertebrate species [1,2,4-7]. Under
normal physiological conditions, the potential damaging ef-
fects of ROS is controlled by robust antioxidant defense
systems. However, excessive formation of free radicals due
to for instance an inflammatory reaction or failing antioxi-
dant capacity as observed in aging, might overwhelm the
antioxidant defense capacity of an organism resulting in
oxidative stress. Oxidative stress may cause structural
damage to nucleotides, lipids and proteins. The neuronall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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http://www.biomedcentral.com/1471-2202/15/56plasmamembrane is particularly prone to oxidative insult
due to its high poly-unsaturated fatty acid (PUFA) content
[8-11]. Many processes participate in the repair of oxidative
damage to cellular components. In the case of membrane
phospholipids, members of the Phospholipase A2 (PLA2)
family of fatty acid acylases that catalyze hydrolysis of sn-2
lipid bonds in glycerophospholipids are key players [12,13].
PLA2’s promote the formation of lysophopholipids and free
fatty acids (FFAs) such as arachidonic acid (AA) and doco-
sahexaenoic acid (DHA) [14-16]. Under normal physio-
logical conditions PLA2, its products and their metabolites
play essential roles in regulating signal transduction, vari-
ous neuronal signaling pathways, ion channel functioning
and gene transcription processes [15,17-21]. Under condi-
tions of oxidative stress PLA2 is one of the mediators
through which peroxidized fatty acids are excised from the
lipid bilayer matrix [12,15]. Recent evidence increasingly
associates deregulation of lipid metabolism due to PLA2
(over) activation as a cause of nervous system dysfunction
and cognitive impairment [7,12,22,23]. Yet, the physio-
logical mechanisms underlying these phenomena remain
incompletely resolved.
Our current research on the foundations of learning
and memory impairment in the pond snail Lymnaea
stagnalis (L. stagnalis; L.) focuses on the question of
lipid-peroxidation dependent facets of neuronal dysfunc-
tion [6,7,22]. The present study follows from our recent
observations implicating age-, inflammation- and experi-
mental oxidative stress-induced PLA2 activity in long-
term memory (LTM) failure [7,22]. Considering the
pivotal role of PLA2 activation in behavioural plasticity,
we investigated the question whether it is the fatty acids
released upon PLA2 activation that causes cognitive
impairment in our model system. Here we utilized an
established and widely studied classical appetitive reward-
conditioning paradigm involving chemosensory condi-
tioning of the animals’ feeding behaviour i.e., “rasping”
[22,24-27]. Using this model we investigated the ef-
fects of experimentally pro-oxidant induced PLA2 acti-
vation on associative appetitive LTM impairment and
the role of circulating FFAs therein. We will provide evi-
dence that increased levels of circulating (per)oxidized fatty
acids are not a factor in oxidative stress induced LTM
impairment.
Results
Enhanced levels of extracellular PLA2 inhibit LTM
formation
To assess the impact of increased levels of extracellular
PLA2 on the formation of appetitive LTM, animals ran-
domly assigned to two test groups were injected with
PLA2 from bee venom or vehicle-only 1 hr before their
first training session. Animals were subsequently tested for
the presence of conditioned feeding responses 22–24 hrsafter their last training session (Figure 1A). These experi-
ments revealed a prominent suppression of conditioned
feeding responses in animals that received treatment with
PLA2 (Figure 1B; ANOVA interaction time x treatment;
F1,57 = 19.315, p < 0.0001). That is, vehicle-injected condi-
tioned (CS-UCS) animals displayed robust conditioned
feeding responses compared to their non-conditioned
(CS-DS) peers (F1,57 = 35.672 p < 0.0001). In contrast,
PLA2-injected animals displayed a conditioned feeding
response that was significantly reduced compared to the
vehicle conditioned animals (F1,57 = 15.634 p = 0.0002)
and was statistically indistinguishable from their non-
conditioned partners (F1,57 = 0.083, p = 0.77).
AAPH injection elevates circulating FFA levels and causes
PLA2-dependent LTM failure
Prior studies in L. stagnalis implicate natural and experi-
mentally (AAPH) induced non-enzymatic lipid peroxi-
dation to memory deficiencies in an aversive operant
conditioning of aerial respiratory behaviour [7]. We also
demonstrated this phenomenon can be fully reversed
through treatment with the general PLA2 inhibitor aris-
tolochic acid [7]. Therefore, we now proceed with test-
ing whether AAPH treatment also affect non-aversive
appetitive classical conditioning. To this end, we first
evaluated the temporal characteristics of AAPH induced
free fatty acid (FFA) release into the circulatory system.
FFA content of haemolymph extracted immediately or 12,
24, 48, 96 and 168 hours after intracoelomic injection of
AAPH were quantified with ADIFAB-FFA assay. A signifi-
cant increase in haemolymph FFA levels developed over
the first 24–48 hours after AAPH injection (Figure 2;
One-way ANOVA F6,44 = 7.798, p < 0.0001; Planned com-
parison 0 hr vs 24 hrs F1,44 = 21.538, p < 0.0001 and 0 hr
vs 48 hrs F1,44 = 23.536, p < 0.0001). No such increase was
observed when haemolymph was collected 24 hrs after
vehicle injection (Planned comparison 0 hr vs vehicle
24 hrs F1,44 = 0.0025, p = 0.96). FFA levels returned to
control levels 2–4 days after AAPH injection. These data
support the notion that AAPH injection can cause sig-
nificant temporal changes in lipid metabolism within the
whole animal.
Next we tested the effect of AAPH induced oxidative
stress on non-aversive appetitive classical conditioning
and the involvement of PLA2 in this process. To this
end animals were injected 24 hrs before the first training
trial with either vehicle or AAPH. Subsequently, animals
were injected 1 hr before the start of the first training
session with either aristolochic acid or vehicle only
(Figure 3A). We found that treatment with AAPH caused
a significant reduction in the conditioned feeding response
and that treatment with the PLA2 inhibitor aristolochic
acid counteracted AAPH’s negative effect on LTM forma-
















































































































Figure 1 Long-term memory assessments after bee venom PLA2 injection. A. Protocol indicating timing of injection and start of pre- and
post-training tests with respect to the start of the first training session for both the conditioned (CS-UCS) and control (CS-DS) animals. B-D LTM
assessment in animals injected 1 hr before training. In all control animals, rasping movements were similar upon application of the disturbance
stimulus or conditioning stimulus (B). In contrast, in conditioned vehicle injected animals the number of rasping movements increased after
application of the conditioning stimulus (C). The difference between the number of rasps induced by the conditioning stimulus minus the
disturbance stimulus shows that there was a robust response to conditioning but only in the vehicle injected animals. None of the unconditioned
animals or the PLA2 injected conditioned animals responded with significant feeding movements in the post-training test (D). These results indicate
LTM impairment in snails injected with exogenous PLA2 1 hr before training. ***p < 0.001.
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http://www.biomedcentral.com/1471-2202/15/56F3,85 = 2.847, p < 0.05). That is, AAPH treated animals had
a lowered feeding response compared to vehicle treated
conditioned animals (F1,85 = 11.668, p < 0.001) and their re-
sponse was statistically indistinguishable from the non-
conditioned peers (Figure 3B; F1,85 = 0.6016, p = 0.44). In
contrast animals treated with aristolochic acid only learned
well (F1,85 = 13.805, p = 0.0003) in a manner that was statis-
tically indistinguishable from that of vehicle treated ani-
mals (Figure 3B; F1,85 = 0.841, p = 0.36). Moreover, animals
treated with the combination of AAPH and aristolochic
acid did display a significant conditioned feeding response(Figure 3B black bars; F1,85 = 20.047, p < 0.0001) that was
significantly different from the AAPH injected animals
(Figure 3B; F1,85 = 17.219, p < 0.0001). Note that training
and testing trials were performed when AAPH-induced
haemolymph FFA levels were at or close to their peak.
Arachidonic acid does not affect LTM performance
The above results clearly implicate PLA2 as a critical fac-
tor in oxidative stress induced appetitive LTM deficiency.
PLA2 is responsible for the hydrolysis of membrane
phospholipids resulting in the release of FFAs including






















Figure 2 Temporal characteristics of AAPH induced haemolymph
free fatty acid levels. Average ADIFAB F505/F432 relative fluorescence
intensity ratios (RFU) measured in haemolymph samples collected
24 hrs after vehicle injection and immediately or 12, 24, 48, 96, and
168 hrs after intracoelomic injection with AAPH. There is a substantial
and significant increase in F505/F432 ratio when measured 24 hrs and
48 hrs after AAPH injection but not after vehicle injection. *** p < 0.001.
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Arachidonic acid is the primary substrate for the cy-
clooxygenase (COX) branch of the eicosanoid pathway.
We previously showed that systemic immune challenges
cause oxidative stress and induces a PLA2- and COX-
dependent appetitive LTM failure in L. stagnalis [22].
Thus, to test the hypothesis that elevated haemolymph
arachidonic acid levels underlie LTM impairment, ani-
mals were injected with exogenous arachidonic acid or
vehicle-only before their first training session and tested
for the presence of conditioned feeding responses 22–
24 hrs after their last training session (Figure 4A). These
experiments revealed no significant negative effect of ara-
chidonic acid injection on appetitive LTM (ANOVA inter-
action time x treatment; F1,48 = 0.001, p = 0.99; planned
comparison treatment vs training F1,48 = 9.4584, p = 0.003).
Binding of free fatty acids to BSA does not rescue
LTM failure
Above we showed that injection with exogenous arachi-
donic acid prior to training has no effect on appetitive
LTM function. However, arachidonic acid is likely not
the only PLA2-hydrolysis product released with neuro-
modulatory or signaling capabilities. Defatted bovine
serum albumin (BSA) is considered a high affinity FFA
binding protein [28,29]. Thus, we first verified whether
BSA is an effective tool for haemolymph FFA manipula-
tion in L. stagnalis. Animals were injected with AAPHor vehicle-only and 24 hrs later subsequently injected
with defatted BSA or vehicle-only. Two hours after BSA
injections, haemolymph was collected and FFA levels
were determined immediately using the ADIFAB assay.
As before, AAPH injection induced elevated haemo-
lymph FFA (Figure 5; One-way ANOVA F3,19 = 23.695,
p < 0.0001; vehicle vs. AAPH F1,19 = 16.522, p = 0.0006).
Moreover our data showed that BSA effectively binds
FFAs in L. stagnalis haemolymph. That is, naturally occur-
ring FFAs levels are significantly lower after BSA injection
(vehicle vs BSA F1,19 = 19.385, p = 0.0003) and animals sub-
jected to injections of both AAPH and BSA have similar
haemolymph FFA levels as vehicle-only injected animals
(vehicle vs AAPH-BSA F1,19 = 1.519, p = 0.23).
Next we tested whether BSA-injection could reverse
AAPH induced appetitive LTM failure. Animals were
injected with AAPH or vehicle-only 24 hrs before train-
ing and subsequently injected 1 hr before training with
defatted BSA or vehicle (Figure 6A; note that the in-
jection regime was identical as used for the previous
experiment). We found that injection with BSA did not
counter AAPH’s negative effect on LTM formation
(Figure 6). As before, treatment with AAPH caused a
significant reduction in the conditioned feeding re-
sponse compared to vehicle treated conditioned animals
(ANOVA interaction training x treatment, F3,102 = 2.748,
p < 0.05; vehicle vs AAPH F1,102 = 8.7611, p = 0.003). In
contrast, animals treated with BSA-only learned well
(F1,102 = 13.805, p = 0.0003) in a manner that was sta-
tistically indistinguishable from that of vehicle treated
conditioned animals (Figure 6B; F1,102 = 0.0949, p = 0.76).
However, animals treated with the combination of
AAPH + BSA did not display a significant conditioned
feeding response (Figure 6B black bars; F1,102 = 0.5285,
p = 0.47). This conditioned feeding response was dif-
ferent compared to vehicle or BSA treated conditioned
animals (F1,102 = 12.717, p < 0.0001 and F1,102 = 10.26107,
p = 0.002 for vehicle and BSA respectively) but not signifi-
cantly different from the AAPH-only injected animals
(Figure 6B; F1,102 = 0.0183, p = 0.89).
Discussion
This study’s primary purpose was to test the hypothesis
that FFAs released by oxidative stress-induced PLA2 ac-
tivity are a factor in learning and memory dysfunction in
L. stagnalis. Our primary observations are: 1- Increasing
the level of extracellular PLA2 activity through injection
of venom-derived extracellular PLA2 evoked LTM im-
pairment. 2- Experimental induction of oxidative stress
with the lipid peroxidation-inducing free radical generator
AAPH triggers an increase in circulating FFA levels that
peaks within 24–48 hrs and attenuates LTM performance.
3- Experimental elevation of circulating arachidonic acid
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Figure 3 PLA2 inhibition restores LTM deficiency in AAPH injected animals. A. Protocol indicating timing of injection and start of pre- and
post-training tests with respect to the start of the first training session for both the conditioned (CS-UCS) and control (CS-DS) animals. B-D. LTM
assessment in animals injected with either vehicle only (vehicle-vehicle), AAPH only (AAPH-vehicle), aristolochic acid only (vehicle-aacid) or
injected with both AAPH and aristolochic acid (AAPH-aacid). In all control animals, rasping movements were similar upon application of the
disturbance stimulus or conditioning stimulus (B). In contrast, conditioned animals, either vehicle injected, aristolochic acid only or AAPH + aristolochic
acid injected, showed an increase in the number of rasping movements after application of the conditioning stimulus (C). Thus, the AAPH injected
conditioned group, showed a significant reduction in their Δrasp values in the post-training test compared to all other conditioned groups. Animals
injected with aristolochic acid only or AAPH + aristolochic acid were not different in their conditioned response than the vehicle injected
animals (D). This suggests that co-treatment of AAPH with a general PLA2 inhibitor reverses the AAPH induced adverse effect on appetitive
LTM performance. ***p < 0.001.
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http://www.biomedcentral.com/1471-2202/15/56acid does not affect LTM performance. 4. Experimentally
induced oxidative stress-associated LTM impairment can
be rescued with the general PLA2 inhibitor aristolochic
acid but not by normalizing the level of circulating FFAs
with defatted BSA.
The present data substantiate previous evidence where
we link lipid peroxidation and PLA2 activation to age- andoxidative stress-associated LTM impairment in another,
aversive operant conditioning learning and memory para-
digm [7]. In both our learning models age- and oxidative
stress associated LTM failure is associated with reduced
electrical excitability of key interneurons in the circuits
underlying the respective behaviours [6,7,22,30]. Both be-
















































































































































Figure 4 Long-term memory assessment after injection with arachidonic acid. A. Protocol indicating timing of injection and start of
pre- and post-training tests with respect to the start of the first training session for both the conditioned (CS-UCS) and control (CS-DS) animals.
B-D. LTM assessment in animals injected 1 hr before training. There was a robust response to conditioning in both vehicle and arachidonic acid
injected animals. Thus all conditioned animals responded with significant feeding movements in the post-training test upon application of the
conditioning stimulus. These results indicate that injection with exogenous arachidonic acid does not induce LTM impairment in snails.
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http://www.biomedcentral.com/1471-2202/15/56respiratory and appetitive LTM impairment can be repro-
duced in young animals through treatment with AAPH,
a water-soluble free radical generator commonly used
to induce FA peroxidation (present study and [7]). In
addition, in both our two models, all behavioural, elec-
trophysiological and biochemical symptoms of aging
and experimental oxidative stress can be reversed by
treatment with aristolochic acid, a broad spectrum
PLA2 inhibitor (present study and [6,7,11]). No evidence
was found of significant age-associated impairment or
experimental oxidative stress-induced repression of short/
intermediate term forms in either of the two behav-
ioural conditioning paradigms [7,27], suggesting thattranscription-independent forms of memory are relatively
impervious to aging or oxidative stress. Intriguingly, se-
lective appetitive LTM impairment could also be induced
in young Lymnaea through systemic activation of their
cellular immune system and, as before in aged and
oxidation-stressed young animals, LTM could be rescued
by means of PLA2 inhibition [22]. Thus, although, the
possibility exists that the cellular and molecular mecha-
nisms underlying oxidative stress induced PLA2 activa-
tion dependent LTM impairments in our two learning
models are different, this seems unlikely. The brain and
its neurons are due to their high polyunsaturated fatty













































Figure 5 BSA binds circulatory free fatty acids. Average ADIFAB
F505/F432 fluorescence intensity ratios (RFU) measured in haemolymph
samples collected 24 hrs after injection with either vehicle only
(vehicle-vehicle), AAPH only (AAPH-vehicle), BSA only (vehicle BSA), or
injection of both AAPH and BSA (AAPH-BSA). Note that timing and type
of injections were identical as for the behavioral assessment depicted in
Figure 6A. BSA-only injection significantly reduces F505/F432 ratio when
compared with vehicle only injected animals. There is a significant
increase in F505/F432 ratio after AAPH injection. This effect was eliminated
in the combined AAPH-BSA treatment group. **p < 0.01.
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http://www.biomedcentral.com/1471-2202/15/56attack, oxidative stress and subsequent peroxidation,
a process that if not properly contained can severely
disrupt membrane architecture and lipid signaling pro-
cesses [31-33]. Neurons defend themselves against lipid-
peroxidation through various mechanisms, one that
involves excision of (per)oxidized FA by PLA2 [12,15].
As will be discussed below, PLA2, (per)oxidized FA and
their various metabolites all can alter signal transduc-
tion, various neuronal signaling pathways, ion channel
functioning and gene transcription processes and ul-
timately behavioral plasticity such as learning and memory
processes. Thus, although to our knowledge our studies
are the first to show these aspects in molluscs, it is not
surprisingly that similar conclusions are drawn with in-
creasing frequency in studies linking oxidative stress re-
lated PLA2 activation with cognitive impairment, neuronal
dysfunction and disease not only in other, non-molluscan,
invertebrate species but also in mammals and humans
[12,16,34-38]. Together this suggests that Lymnaea’s LTM
functions in general are sensitive to lipid peroxidation and
oxidative membrane damage, and that lipid peroxidation-
dependent activation of PLA2 is a fundamental and evolu-
tionary conserved factor in the decline in behavioral andneuronal plasticity widely observed across the animal
kingdom.
Activation of PLA2 by reactive oxygen species in
L. stagnalis results in the release of extracellular (per)ox-
idized FFAs (present study and [7]). Many FFAs, includ-
ing AA and DHA the two FAs most commonly found at
the glycerophospholipid sn-2 position in neurons, have
various demonstrated biological activity in the nervous
system. For instance, under normal conditions they can
regulate membrane fluidity and other aspects of phospho-
lipid membrane microarchitecture, may engage in mod-
ulatory interactions with various ion channels, affect
alterations in membrane protein clustering, modify re-
ceptor sensitivity and signal transduction pathways as
well as affect gene transcription processes [17-21,39-43].
However, under conditions of oxidative stress, causes
(over) activation of PLA2 resulting in peroxidized FA exci-
sion from the lipid bilayer matrix [12,15]. Recent evidence
increasingly associates deregulation of lipid metabolism
due to PLA2 (over) activation as a cause of nervous system
dysfunction and cognitive impairment [7,12,22,23]. In
addition, AA is the substrate for many potentially neuro-
active lipids metabolized including those generated by the
eicosanoid metabolic pathways. Each of the three main
branches of eicosanoid metabolism, the epoxygenase or
CYP-450, the lipoxygenase (LOX) and the cyclooxygenase
(COX) pathways, has the potential to generate a var-
iety of lipid-derived neuromodulatory substances that
may engage with either intracellular or extracellular tar-
gets [16,18,20,41,44]. In addition, (per)oxidized FFAs
can undergo further metabolic processing resulting in
the production of highly cytotoxic aldehydes such as
4-hydroxynonenal and malondialdehyde [1,14].
Interestingly, we recently showed that challenging the
immune system impairs LTM function in L. stagnalis
that seems to involve PLA2 and COX activity [22]. In
addition, non-enzymatic lipid peroxidation (including
AAPH induced), has been shown to result in the pro-
duction of AA and DHA derived iso- and neuroprostanes
including the LOX series [45,46]. PLA2- and/or LOX-
dependent arachidonic-acid modulated background K+
channels have been described in Lymnaea and various
other molluscs [47-51]. Opening of these 4TM2P channels
generates an outward current. It is therefore conceivable
that elevated levels of PLA2-activity associated with inflam-
mation, oxidative stress and aging induce a decline in
neuronal excitability through activation of these 4TM2P
background K+ channels. In this respect the 12-LOX prod-
uct 12-HPETE, first described in the gastropod Aplysia
californica, is quite interesting. 12-HPETE has long been
known as an activator of Aplysia’s S-type K+-channels [52].
These K+ channels, later identified to belong to the TREK-
1 family, are instrumental in non-synaptic forms of plasti-
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Figure 6 Sequestering circulating FFAs with BSA does not restore LTM failure in AAPH injected animals. A. Protocol indicating timing of
injection and start of pre- and post-training tests with respect to the start of the first training session for both the conditioned (CS-UCS) and
control (CS-DS) animals. B-D. LTM assessment in animals treated with vehicle-only (vehicle-vehicle), AAPH only (AAPH-vehicle), BSA only (vehicle-BSA)
or injections of both AAPH and BSA (AAPH-BSA). In all control animals, rasping movements were similar upon application of the disturbance stimulus
or conditioning stimulus (B). In contrast, conditioned animals, either vehicle injected or BSA only injected, showed an increase in the number of rasping
movements after application of the conditioning stimulus (C). Thus, both the AAPH-only and AAPH-BSA injected conditioned groups, showed a
significant reduction in their Δrasp values in the post-training test compared to the other conditioned groups. Animals injected with aristolochic
acid only were not different in their conditioned response than the vehicle injected animals (D). This suggests that co-treatment of AAPH with
BSA, does not reverse the AAPH induced adverse effect on appetitive LTM performance. **p < 0.01; ***p < 0.001.
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http://www.biomedcentral.com/1471-2202/15/56withdrawal reflex [53] and are implicated as synaptic
modulator in Aplysia and various vertebrate model systems
[54-58]. Alterations in receptor sensitivity, ion channels
and signal transduction pathways as well as affect gene
transcription by PLA2, it’s products and their metabolites
will most likely affect activity,- transcription- and protein
synthesis-dependent processes such as LTM formation.
Based on the evidence described above it seems
therefore very plausible that lipid-peroxidation evokedelevated levels of FFAs through activation of PLA2 are
the source of the observed LTM dysfunction in L. stagnalis
(present study and [7,22]). However, in the present study
we show that increasing extracellular levels of AA does
not affect LTM performance in L. stagnalis. Moreover,
we also show in the current study that removing AAPH-
induced elevated levels of circulating peroxidized FFA
with BSA does not rescue LTM failure in our model
system.
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http://www.biomedcentral.com/1471-2202/15/56So, if not extracellular FFAs then what might be a
source of the lipid-peroxidation dependent LTM failure
observed in L. stagnalis? The first possibility is that
PLA2 itself is the main culprit. The PLA2 family is a
family of heterogeneous enzymes acting in different cel-
lular locations and to some extent different activation
profiles usually classified into intracellular located cyto-
solic PLA2 (cPLA2), calcium-independent PLA2 (iPLA2),
extracellular acting secretory PLA2 (sPLA2) and the re-
cently identified lysosomal and adipose-specific PLA2’s
[15,34,59]. Upon activation, the various PLA2 family
members such as cPLA2 and sPLA2 can induce FA re-
lease and eicosanoid production by themselves [60-62].
In addition, recent evidence also indicates the existence
of cross-talk and trans-activation between the various
intracellular and cytosolic PLA2 family members [63-65].
Thus it is quite conceivable that AAPH, a water-soluble
extracellular free radical generator used to induce lipid
peroxidation in the present study activates various intra-
cellular and extracellular PLA2 enzymes.
Besides being present and acting on the cellular plas-
mamembrane both cPLA2 and iPLA2 can localize and/or
target organellar membranes including mitochondrial
and nuclear membranes [34,66-68]. For instance, it has
been shown that activation of PLA2 can induce mito-
chondrial dysfunction due to a loss of mitochondrial
membrane potential, swelling of mitochondria and/or
the production of superoxide from mitochondria [69].
Furthermore, interactions between cPLA2 and NADPH-
oxidase complexes in the plasmamembrane have been
implicated in the redox-pathology of various neurode-
generative diseases [34,70]. In addition to their poten-
tial interference with numerous signaling processes,
PLA2 enzymatic activity may impact various membrane
architecture-sensitive processes. For example, PLA2 may
alter phospholipid-packing causing membranes to be-
come more molecularly ordered and affect processes in-
volved in vesicle fusion, exocytosis and actin-dependent
processes [71-75]. Moreover, there is evidence that archi-
tectural changes induced by PLA2 may alter gating states
for a variety of ion channels including members of the
K2P two-pore “leak” potassium family [76,77]. At this
point in time we cannot say if and which of these scenar-
ios underpins LTM impairment in our model system.
Nor can we pinpoint which PLA2 is involved. However,
the observation in the current and one of our previous
studies [7], that treatment with aristolochic acid, com-
monly considered a general PLA2 inhibitor and inhi-
biting various classes of PLA2 [68,78-81], reverses the
AAPH-induced LTM failure is consistent with PLA2’s
involvement.
Another intriguing potential scenario to consider as
explanation for the current results is the possibility
that other products released extracellular after PLA2activation are causing LTM failure in L. stagnalis. For
instance, hydrolysis of oxidized membrane phospho-
lipids by PLA2 will not only liberate FFAs but also pro-
duce lysophospholipids (LPLs). Involvement of LPLs in
membrane-associated processes such as membrane bud-
ding, ruffle formation, protein complex assembly and ion
channel gating has been reported [34,59,82-85]. However,
extracellular LPLs, like FFAs, can bind to BSA [86-88].
Therefore, we currently interpret BSA’s inability to re-
verse AAPH-induced LTM deficiency as evidence against
the idea that circulating LPLs play a major role in the
current LTM failure model. Alternatively, extracellular
(per)oxidized FAs can undergo further metabolic pro-
cessing resulting in the production of highly cytotoxic al-
dehydes such as 4-hydroxynonenal and malondialdehyde
[1,14]. It is important to note that BSA is not cell perme-
able. Thus, indirect activation of intracellular PLA2 might
cause elevated levels of intracellular FFAs and LPLs
thereby affecting various intracellular targets [14,89,90].
For instance, it has been demonstrated that increased
levels of intracellular FFAs can directly affect NADPH-
oxidase [90,91] resulting in a further increase of ROS and
lipid peroxidation [91].
In addition to FFAs and LPLs, PLA2 activation results
in the extracellular release of lyso-platelet-activating fac-
tor (lyso-PAF), the platelet-activating factor (PAF) pre-
cursor [92-94]. PAF is a bioactive phospholipid that
under normal conditions is thought to be involved in the
regulation of synaptic plasticity, memory and neuronal
protection [92-94]. In addition, PAF is a transcriptional
activator of the cyclooxygenase-2 (COX-2) gene [92]. As
noted before, AA is the primary substrate for the COX
branch of the eicosanoid (inflammatory) pathway. Im-
portantly, ROS can also be generated as a by-product of
COX activity, thus creating a positive feedback loop that
potentially can cause escalation of PLA2, PAF and COX-
activity thereby causing substantive deregulation of lipid
homeostasis [92-94]. In this respect it is interesting to
note that we recently showed that systemic immune chal-
lenges in L. stagnalis induces a PLA2-dependent LTM
failure that could be rescued with treatment of indometh-
acin, a putative COX inhibitor [22].
One of the intriguing questions still remaining is why
inhibition of PLA2 24 hrs after its activation is sufficient
to reverse the oxidative stress induced LTM failure? We
show in the present study that circulating FFA levels are
their highest level 24–48 hrs after PLA2 activation sug-
gesting that some of the PLA2 and FFA-dependent and
associated pathways are initiated in the first 24 hrs. after
induction of oxidative stress. At present we cannot de-
finitively provide a mechanism to what causes the PLA2-
dependent LTM failure within this time frame. However
based on the actions of PLA2, FFA and their various
products as outlined above there are some potential
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biting PLA2 activity, even though FFAs are already re-
leased for some time, we stop the positive feedback loop
discussed above, thereby preventing further escalation of
PLA2, its products and their pathways. Notwithstanding,
further investigations are clearly needed to resolve this
issue.
Conclusion
The current results support our earlier work where we
link oxidative stress, lipid metabolism and age-associated
LTM impairment in L. stagnalis. In the present study,
we provide evidence that lipid peroxidation induced ele-
vated levels of circulating FFA do not impact LTM per-
formance. This is of particularly interest considering the
increasing focus on the interplay between ROS, PLA2,
COX, their substrates and metabolites as a potential fac-
tor in the deregulation of lipid metabolism and cell- and
neuronal dysfunction and cognitive performance.
Methods
Animals
Animals were bred and raised under constant and
strictly controlled ambient conditions as previously de-
scribed [6,7,11,22,27,30,95]. Water used in the facility
was sourced from a reverse osmosis system and recondi-
tioned to a conductivity of ~450 Ω.cm through the
addition of Instant Ocean salts at 1 g/US Gallon (i.e.,
artificial pond water; Aquarium Systems USA). Calcium
concentration was kept at saturation level (~60 mg/L as
CaCO3) through the addition of calcium carbonate (light
powder; EMD analytics, Gibbstown, New Jersey) to the
tanks. In addition, animals had continuous access to
sterilized cuttlefish (Sepia officinalis) bone (2–3 per
tank). Animals were fed a routine diet consisting of
Romaine lettuce and Aquamax-carniverous Grower 600
trout pellets ad libitum (Purina Mills LLC, St. Louis,
Missouri). For the present study, young sexually mature
snails (age 7–9 months; shell length 2.5 cm-3 cm; see
also [7]) were taken at random from healthy populations.
The use and care of animals conformed to the University
of Calgary Animal Care and Use Policy which adheres to
the guidelines, policies and standards of the Canadian
Council on Animal Care (CCAC), the Canadian Associ-
ation of Laboratory Animal Medicine (CALAM), standards
of Veterinary Care, and the Alberta Veterinary Association
(AVMA) professional codes and standards.
Training and testing procedures
Preparation
Behavioural conditioning was done using a non-aversive
appetitive classical conditioning protocol [22,27]. Snails
were sampled at random and marked, for identification
purposes with indelible marker. Food was withheld starting48 hrs prior to the first pre-training test and for the re-
mainder of the training and post-training testing.
Testing procedures
On day 1, prior to behavioural conditioning, each snail
was individually tested for their natural response to the
administration of pond water, the disturbance stimulus
(DS), as well as the conditional stimulus (CS) n-amyl
acetate (“Pre-training test”) [22]. Tests were performed
using 100-ml translucent polystyrene beakers (4.5 cm
diameter), filled with 80 mL of water taken from the
snail’s home tank. After transfer into the beakers, the
snails were allowed to acclimatize for 15 min before test-
ing commenced. Testing involved counting the number
of rasps over two consecutive periods of 2 min, the first
period starting with gentle administration of the DS
(10 ml artificial pond water), the second period starting
with the administration of the CS (10 ml n-amyl acetate
solution; 4 ppm final concentration). To facilitate obser-
vation, the test beakers were elevated by translucent
plastic stands and were surrounded by mirrors to ensure
continuous view of the buccal mass and radula of the
snails during testing. A test response was calculated by
taking the difference between the number of rasps
counted during the second period minus the number
counted during the first period (i.e., ΔRasp = rasps after
CS – rasps after DS). To correct for both differences in
background rasping activity and potential application
artefacts, the pre-training tests were performed in du-
plicate with >1 hr interval, and behavioural responses
were calculated as the average of both ΔRasp (i.e.,
ΔRasppre-test = average ΔRasppre-test1 and ΔRasppre-test2).
After completion of a test, snails were gently rinsed and
returned to their home tanks. A single post-training test
was performed on day 3 (22–24 hrs after training) fol-
lowing identical procedures as described for the pre-
testing above.
Training procedure
Snails were trained in a single day, multi-trial forward-
delay conditioning format [22]. Sucrose (final concen-
tration of 0.4% wt/vol) served as the unconditioned
stimulus (UCS) and n-amyl acetate (4 ppm final con-
centration) as the conditioned stimulus (CS). To control
for potential behavioural effects of fluid addition, a dis-
turbance control in which the UCS was paired with the
DS (i.e., pond water) was implemented. Snails were ran-
domly assigned to either the CS–UCS (“conditioned”) or
the CS–DS (unconditioned “control”) group and trained
“en masse”. Training was performed in 1-L polypropylene
beakers containing 480 ml clean artificial pond water.
After transfer into the training beakers, the snails were
allowed to acclimatize for 60 min. Both “control” and
“conditioned” groups received 120 mL of the CS solution,
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group) or 120 ml of the DS (“control” group). After 2 min,
the beakers containing the snails were drained and gently
rinsed with clean pond water and the snails were readied
for their next training trial by re-placing them in the 1-L
polypropylene beakers holding 480 ml clean artificial pond
water. After 11 min and 45 sec the training procedure was
repeated. Snails received a total of 5 training procedures
on a single day before being returned to their “home” tank.
Snails were at all times fully submerged during training
and testing. Care was taken to ensure that pre-testing,
training and post-testing commenced at the same time of
day for each group and training and testing always oc-
curred in the same location. “Conditioned” and “control”
snails were always tested and trained concurrently.
Chemicals and drug injections
All chemicals used in this study i.e., defatted bovine al-
bumin serum (BSA; fatty acid free), aristolochic acid,
arachidonic acid, Phospholipase A2 from honey bee
venom and 2,2-azobis (2-methylpropion-amidine) dihy-
drochloride (AAPH) were obtained from Sigma Aldrich
(St. Louis, MO). All drugs, except arachidonic acid, were
dissolved in sterile ultrapure water. Arachidonic acid was
dissolved in dimethyl sulfoxide (DMSO). To prevent pre-
mature oxidation of dissolved AA, the drug was either
used immediately after dissolving or stored under nitro-
gen at −20°C. Drug or vehicle-only treatments were de-
livered by means of intracoelomic injection into the snail
(note: this will introduce drugs directly into the animal’s
blood and circulatory system) in a manner avoiding
whole-body withdrawal responses and voiding of haemo-
lymph [7,22,30]. Using body weight measurements injected
amounts of drugs were calculated to achieve the following
approximate concentrations of drugs in the snails’ haemo-
lymph: 1 mM of AAPH, 2 mg/ml of BSA, 20U of PLA2,
10 μM of both arachidonic acid and aristolochic acid.
Haemolymph DMSO concentrations never exceeded
0.05%. As control snails were injected with equivalent vol-
umes vehicle only (vehicle control). Except for AAPH
injected 24 hrs before training, all other injections
were given 1 hour prior to the start of the first train-
ing trial. AAPH is a water-soluble slowly dissociating
azo-compound used extensively as a free radical generator
in studies of lipid peroxidation and characterization of anti-
oxidants in various model systems including L. stagnalis
[6,7,96,97]. All solutions were injected through the foot dir-
ectly into the haemocoel with a microliter syringe and a
25G needle. Animals were behaving normally within 1–2
minutes after injection.
Haemolymph extraction and free fatty acid detection
Snails were injected with AAPH, BSA, AAPH + BSA or
vehicle-only using the same injection schedule as for thebehavioural assays. Haemolymph was extracted by head–
foot retraction [98]. Haemolymph collected of 3 snails/
condition was pooled. Free fatty acid levels were quan-
tified using standard protocols involving acrylodan la-
beled intestinal fatty acid binding protein (ADIFAB;
FFA Sciences, San Diego, CA) [7,99,100]. Haemo-
lymph plus ADIFAB (0.2 μM) was loaded on a 96-well
plate. Fluorescent signal was measured immediately using
a Spectromax 2Me multidetection microplate reader
(Molecular Devices, Sunnyvale, CA) with and excitation
wavelength of 386 nm and emission wavelength of 432
and 505 nm representing respectively unbound and bound
states of ADIFAB. Data are expressed in dimensionless
fluorescence intensity units (RFU) determined from inten-
sity ratios measured at 505 and 432 nm (F505/F432; see
[99]). An increased F505/F432 ratio is indicative of increased
haemolymph free fatty acid levels [99,100]. Six or more in-
dependent experiments with each 3 replicates/condition
were performed.
Statistical analysis
Behavioural data was analyzed by means of a factorial
or repeated measure ANOVA. Explicit hypotheses were
tested using planned comparisons unless indicated differ-
ently in the text. Effect of drugs on FFA production was
analyzed by one-way ANOVA. Compliance with para-
metric assumptions was confirmed for each data set sub-
mitted to ANOVA using both graphical (probability plots
applied to raw data and residuals) and analytical tech-
niques (Kolmogorov-Smirnov one-sample test for nor-
mality, F-max test). Throughout the text, average and data
dispersion are expressed as arithmetic means and standard
error of the mean (SEM). Figures were constructed using
Graphpad Prism version 4.03 (Graphpad Sofware Inc.,
La Jolla, CA).
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